Clinical trials and research

Joining a trial or study

Overview

You may find out about current clinical trials and other research studies from your cancer specialist, your hospital’s clinical trials nurse, clinical trials websites, and patient groups.

You can only join a trial or study if you meet the eligibility criteria. This is because everyone in the group needs to have some similar characteristics.

There are lots of things to consider when deciding whether to join a trial or study, such as the impact of the study on your wellbeing and lifestyle. You need to weigh up the benefits and risks before deciding that the study is right for you. If you decide to take part, you will need to confirm that you understand the purpose, risks and possible outcomes of the research (informed consent).

Last updated:

Finding a trial or study

There are many ways to find out about clinical trials and other research studies. Most cancer specialists know about current studies and may recommend you join a suitable study, or you can ask them if there are any trials you can consider. If your hospital has a clinical trials or research nurse, you can also ask them about current studies. You don’t have to join a study at your current treatment centre – your doctor can refer you to a suitable trial at another centre.

Hospital and treatment centre waiting rooms often have information about current studies, or you might hear about a study through patient support groups, in the general media or through social media (such as Facebook). Before providing any personal information, especially via social media, check the study with your doctors.

You can also search clinical trials websites. If there isn’t a suitable study available right now, you can register through the Center for Analysis of Rare Tumors, and they will tell you about any studies that come up in the future.

If you find a trial or study you’re interested in joining, discuss it with your cancer specialist. You can ask them if you meet the eligibility criteria and, if so, whether they could coordinate your involvement or put you in touch with the research team.

Deciding to take part

You may have many questions when deciding whether to join a clinical trial. As well as talking to your doctor and clinical trials nurse, it is a good idea to talk to people close to you, such as your family, carers or close friends. Ultimately, though, it’s your decision to participate in research or not to participate.

You shouldn’t feel pressured to take part in research, and you should not feel rushed into making any decisions that may affect your health or treatment. Ask your doctor or nurse how much time you have to think about whether or not to join a study. You should usually be given at least a few days to consider the participant information. If you would like to take more time to think about it, ask if it is safe to wait a bit longer before starting treatment. If you decide not to join a study, you will still receive the standard treatment for the cancer, and it won’t affect your relationship with your treatment team.

Weighing up the benefits and risks


  • Consider what is most important to you. Some people prefer to have standard treatment with predictable side effects, whereas others want to try something new even if the benefits are not yet proven or it may have unknown side effects.
  • Think about how the study might affect your health, wellbeing and lifestyle. What is the chance of any serious side effects? Will any parts of the study be too difficult (e.g. having to have extra tests or trips to the hospital)?
  • Weigh up these drawbacks and risks against the possible benefits, such as a possibly longer survival time or not having to experience certain side effects.
  • Remember that everyone’s situation is different – what is the right decision for someone else may not be right for you.

Getting a second opinion


Some people like to get a second opinion about whether they should join a research study, particularly if it is a clinical trial.

A second opinion can:

  • confirm or clarify your doctor’s recommendations
  • help you to consider all the advantages and disadvantages of being on the trial
  • reassure you that you have thought about the different issues that might affect you.

If you would like to get a second opinion, ask your general practitioner (GP) for a referral to another cancer specialist, but keep in mind that you may have to wait several weeks for an appointment and you may have to pay extra.

You can also ask your cancer specialist if it is possible to talk to another specialist within the same hospital or treatment centre. Some people also like to discuss the possibility of a trial with their GP.

A clinical trials nurse accompanied me at every stage of the process. She explained what was happening and answered any questions I had.

Marg

Eligibility criteria

Before any clinical trial or other research study begins, researchers develop the protocol for that study. This detailed plan describes the study’s design, the reasons for doing the study, and who can join (known as the eligibility criteria).

The eligibility criteria are the rules for who can take part in the research study. They outline the features that must be shared by all participants to ensure that the people taking part are similar in certain ways. This is so the results of the study will be clearly related to the treatment, not to other individual factors.

Depending on the research, the eligibility criteria may include:

  • age or sex
  • cancer type
  • stage of the cancer
  • symptoms or side effects experienced
  • length of time since diagnosis or treatment
  • previous treatments for the cancer
  • other medical conditions.

Eligibility criteria can be broken down into:

  • inclusion criteria – the features a person needs to have to join a research study
  • exclusion criteria – the features that stop someone from taking part.

The eligibility criteria also help keep people safe by considering things that might make the trial too risky for them. For example, you may be excluded from a trial if you are pregnant, have high blood pressure, or have some other condition that increases the risks of the treatment.

Although there are thousands of different clinical trials occurring around the world at any one time, eligibility requirements can be very specific, and there may not be a trial suitable for your particular situation. For example, if you have metastatic cancer, the disease may have to be active or progressing for you to be eligible to join a particular trial.

Before becoming part of a clinical trial or other research study, all participants have to give “informed consent”. This means you will be asked to confirm you have read and understood the purpose, risks and possible outcomes of the research before deciding to join.

Informed consent involves:

Written information


After talking to you about the study, members of the research team will give you a written document known as the participant information. This written information explains the purpose of the study, what is expected of you if you join, what the possible risks are, how your information will be used, and how the results will be presented. You should read the participant information carefully and note down any questions you have for your doctors and the clinical trials or research team.

Informed consent discussion


After you have read the participant information, you can discuss the study in more detail with the clinical trials or research team. You should ask them to explain any parts of the written information that seemed unclear to you.

Agreement in writing


Once all your questions have been answered, you can then decide whether or not to join the study. If you do choose to take part, you will be asked to sign the informed consent form. This confirms that you understand the purpose of the study, what is involved, and the potential risks and benefits, and that you agree to participate.

For some low-risk studies, written informed consent may not be needed. For example, if you are doing a survey, just completing the survey may be taken as consent, or you may be able to say you consent over the phone.

For people under 18, a parent or guardian has to give legal consent as well. Signing the form is not a contract and you can change your mind at any time. You will receive a copy of the consent form signed by you and the researcher.

The process of informed consent continues throughout the study. If the study changes or new information becomes available while you are involved, you will be given updated participant information. You will need to sign an updated version of the consent form if you are willing to continue.

Sometimes you may need to consent to each aspect of a study. For example, you might agree to take part in a trial of a new surgical procedure, and then need to consent for your tissue to be collected and banked during that surgery. You might also need to consent again if you are given an extra survey or interview.

Contact person

All clinical trials and other research studies have a contact person. You can talk with this person before you decide to take part and at any stage during the study if you have questions or concerns. The contact person is often a clinical trials nurse or study coordinator.

You will also be given details of who to contact if you have a complaint about the study (e.g. about how the study was run or how you were treated). This person is independent of the research team and is usually a senior member of the human research ethics committee. Complaints about research are rare, but it is your right to have your concerns heard if you have a problem.

Participant information

Researchers must provide written information about the research study to anyone thinking about joining. This is called participant (or patient) information. It answers a range of questions about the study, including:

  • the purpose of the study
  • if it is a clinical trial, and what phase it is in
  • who can participate in the study
  • who is running the study (institution and researchers)
  • who has approved the research
  • who is funding the study
  • how the study will be run and what you need to do
  • how the study will be monitored
  • whether you will need to have tests, scans or other procedures
  • how long you need to be involved
  • where you need to go for appointments, treatments or meetings
  • whether the researchers need to see your medical records
  • whether you will be paid back (reimbursed) for any expenses related to the study (e.g. transport or parking costs)
  • information about possible side effects or other risks
  • information about possible benefits
  • any restrictions on things you can do while you are on the study (e.g. treatments you can’t have)
  • who to contact for more information or if you have any problems or complaints during the study
  • information about your rights, such as keeping your records private (see below) and your ability to withdraw from a study.

My doctor suggested I take part in a study, and I thought it sounded beneficial. I found the thorough disclosure of both the trial and the possible side effects reassuring.

Piers

Privacy

Medical records are private and confidential, including those about your involvement in a clinical trial or any other research study.

Health professionals directly involved in your care or study can access your personal and medical information, but only if it’s necessary for their work. They can’t give any information about you to others unless it is relevant to your health care or the study.

Clinical trials and other research studies collect personal data about you. The participant information may mention who will and won’t have access to your personal data. For example, it might state that your regular treatment team won’t see your survey responses, but the researchers will. You might be asked to consent to the research team seeing your existing medical records or particular test results.

Information collected during the study is often de-identified. In most cases, this means that your name will be removed and replaced with a unique participant number so your identity cannot be revealed unless necessary, e.g. for safety reasons. Being de-identified means when the results are published in medical journal articles or discussed at medical conferences, you will not be named.

If you have questions or concerns about your privacy in a clinical trial or other research study, talk to the clinical trials or research nurse. For general information about privacy issues in health care, talk to the social worker at your hospital or see Protecting your health information.

At the end of a clinical trial, all personal information is stored in a secure place for at least 15 years before it can be destroyed. This is a legal requirement.

 

Relevant support

Australian Cancer Trials

Cancer Australia

Services offered

Information about clinical trials
View detail

Find support services

Find the right services for your needs, wherever you are in Australia

Read cancer information

Trusted cancer information for all people affected by cancer

Need to talk to someone?

We're available 9am - 5pm, Monday to Friday (excluding public holidays)